(Q51053111)

27 March 2018

title

Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients (English)

1 reference

27 March 2018

0 references

1 reference

4

Undine E Lang

1 reference

27 March 2018

author name string

Maria C Jockers-Scherübl

1

1 reference

27 March 2018

Uta Matthies

2

1 reference

27 March 2018

Heidi Danker-Hopfe

3

1 reference

27 March 2018

Richard Mahlberg

5

1 reference

27 March 2018

Rainer Hellweg

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

27 March 2018

Journal of Psychopharmacology

published in

1 reference

27 March 2018

volume

17

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

439-445

1 reference

27 March 2018

Changes in human plasma nerve growth factor level after chronic alcohol consumption and withdrawal

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Behavioral effects of cannabinoid agents in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Cannabis dependence in young adults: an Australian population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Personality, drug of choice, and comorbid psychopathology among substance abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Therapeutic potential of cannabinoids in CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Specific attentional dysfunction in adults following early start of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Immune Abnormalities in Schizophrenia: Evidence for the Autoimmune Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

The time course of nerve growth factor content in different neuropsychiatric diseases--a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

delta 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Insights Into the Role of the Cholinergic Component of the Septohippocampal Pathway: What Have We Learned from Experimental Lesion Studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

The new epidemiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Persistence of haloperidol in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Nerve growth factor: from neurotrophin to neurokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Physiology of the neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Neurotrophins and brain insults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Cannabis use and mental health in young people: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Schizophrenia as a developmental disorder of the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Therapeutic aspects of cannabis and cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Serum nerve growth factor concentration and its role in the preclinical stage of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Cognitive functioning of long-term heavy cannabis users seeking treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

NGF deprivation of adult rat brain results in cholinergic hypofunction and selective impairments in spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

Cell biology of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174007

21 January 2018

Identifiers

DOI

10.1177/0269881103174007

1 reference

27 March 2018

release_sxmj5wsqevhjrdkf5cwndqzrxy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sxmj5wsqevhjrdkf5cwndqzrxy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

27 March 2018